Delivery Order SPE2DB22D1017-SPE2DB25FF8FJ
Award Date
3/20/25
Potential Completion Date
4/10/25
Potential Value
$1.7K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,990.36, is for the delivery of KEDRAB 300 UNIT/2 ML VIAL 2ML medical products. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,626.70 delivery order contract is for the supply of KEDRAB, a 1,500 unit/10 ML vial medication, with a performance period ending on April 24, 2025. The contract is a firm fixed-price, non-set-aside award. AmerisourceBergen Drug Corp holds a substantial $999,999,999.00 Indefinite Delivery Contract (IDC) with the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,621.30 Firm Fixed Price delivery order is for the supply of KEDRAB 300 UNIT/2 ML VIAL 2ML, a medical product. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award, valued at $3,248.76, was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The contract is a delivery order for the supply of 1,500 units of the KEDRAB 10 ML vial, a pharmaceutical product. The contract has a firm fixed price pricing type and an ultimate completion date of September 30, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) between...
This federal contract award, valued at $1,228.80, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract is for the delivery of KEDRAB 300 UNIT/2 ML VIAL 2ML, a medical product. The award is a Delivery Order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,990.36, is a Delivery Order for the supply of KEDRAB 300 UNIT/2 ML VIAL 2ML, with an ultimate completion date of April 28, 2025. The contract is Firm Fixed Price and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery...
This federal contract award, valued at $3,248.76, was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 1,500 units of the drug KEDRAB, a 10 ml vial, with an ultimate completion date of August 28, 2024. This is a firm-fixed-price delivery order contract, and there is no set-aside designation. Amerisourcebergen, through its extensive supply chain network,...
This federal contract award, valued at $1,945.62, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of KEDRAB 300 UNIT/2 ML VIAL 2ML. The contract is a Delivery Order, with a Firm Fixed Price pricing type, and an ultimate completion date of September 25, 2024. This award does not have a set-aside designation. AmerisourceBergen Drug Corp holds significant Indefinite Delivery Contracts (IDCs) with the DLA Troop...
This federal contract award, valued at $3,248.74, was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division. The delivery order is for the supply of 1,500 units of the pharmaceutical product KEDRAB, a 10 ML vial, to support the agency's medical requirements. AmerisourceBergen, a major pharmaceutical distributor, has been awarded numerous federal contracts and Indefinite Delivery Contracts (IDCs) by the DLA and other agencies to provide a wide range...
This federal contract award, valued at $1,626.70, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for 1,500 units of the medication KEDRAB, a 10 ML vial, with a performance period that extends through March 13, 2025. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00, which...